Role of Nanobacteria in Human Calcifying Disease
Role of Nanobacteria in Human Calcifying Disease
批准号:
6614125
负责人:
John C Lieske
金额:
$14.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2005-07-31
关键词:
atherosclerosis bacteria bacteria characteristic bacterial DNA calcification clinical research disease /disorder etiology genetic markers human subject laboratory rat microorganism classification microorganism culture nephrolithiasis nucleic acid sequence pathologic process patient oriented research
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Inflammation is characteristic of human calcifying diseases, including nephrolithiasis and atherosclerosis. While evidence has linked infectious agents to the inflammation present in atherosclerosis, factors that contribute to the calcification remain to be identified. Preliminary data are presented demonstrating that nanobacteria, a novel, slow-growing microorganism which forms a mineralized shell, can be isolated from diseased, calcified tissues of humans and experimental animals. Therefore, the central hypothesis of this proposal is that nanobacteria are a previously unexpected pathogenic factor in these human diseases. Nanobacteria remain controversial in the scientific community because genetic material has not yet been identified. Therefore, the major goal of this two-year R-21 proposal is to clone and characterize unique nanobacterial DNA sequences in order to unequivocally identify and classify this organism, and to develop definitive genetic tests for evaluating human and experimental tissues. A multidisciplinary team has been created with the long-term goal to isolate nanobacteria from tissue of humans and experimental animals, grow the isolates in culture, and then inoculate experimental animals and cells with the organism to reproduce a calcific response, as required to fulfill Koch's postulates. Distinct advantages of this grant application include the vast experience in Laboratory Medicine for extracting, concentrating, and purifying nucleic acid and developing rapid molecular diagnostic tests for infectious disease agents, as well as the use of cryogenic microcomputer tomography (CT) which allows 3D imaging, histomorphometric/immunological imaging, and genetic probing of a single sample. This is a HIGH-RISK proposal, but if nanobacteria are routinely identified in diseased and calcified renal and atherosclerotic tissue, our understanding of these common human diseases would be revolutionized and HIGH-IMPACT consequences would likely ensue, including new treatment approaches for these and possibly other calcifying diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Admin Core
-
批准号:10595344
-
项目类别:
-
资助金额:$3.98万
-
财政年份:2022
-
负责人:John C Lieske
-
依托单位:
Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice
-
批准号:10708970
-
项目类别:
-
资助金额:$39.41万
-
财政年份:2022
-
负责人:John C Lieske
-
依托单位:
Admin Core
-
批准号:10708971
-
项目类别:
-
资助金额:$3.98万
-
财政年份:2022
-
负责人:John C Lieske
-
依托单位:
Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice
-
批准号:10595343
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2022
-
负责人:John C Lieske
-
依托单位:
Research Project
-
批准号:10595345
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2022
-
负责人:John C Lieske
-
依托单位:
Research Project
-
批准号:10708974
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2022
-
负责人:John C Lieske
-
依托单位:
Improving stone disease treatment by accurate phenotyping and risk stratification
-
批准号:9135351
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2013
-
负责人:John C Lieske
-
依托单位:
Improving stone disease treatment by accurate phenotyping and risk stratification
-
批准号:8598968
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2013
-
负责人:John C Lieske
-
依托单位:
Improving stone disease treatment by accurate phenotyping and risk stratification
-
批准号:9343372
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2013
-
负责人:John C Lieske
-
依托单位:
Genetic determinants of urine lithogenicity
-
批准号:7920691
-
项目类别:
-
资助金额:$10.08万
-
财政年份:2009
-
负责人:John C Lieske
-
依托单位:
Defining the natural history and treatment options for Dent Disease
-
批准号:7934954
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2009
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:7984836
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2009
-
负责人:John C Lieske
-
依托单位:
Pilot and Feasibility Program
-
批准号:7934955
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2009
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:7984844
-
项目类别:
-
资助金额:$6.42万
-
财政年份:2009
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:7924752
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
Genetic determinants of urine lithogenicity
-
批准号:7570682
-
项目类别:
-
资助金额:$40.82万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:7589347
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:8533495
-
项目类别:
-
资助金额:$5.18万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:8328100
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:8150214
-
项目类别:
-
资助金额:$2.88万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
国内基金
海外基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
-
批准号:81971557
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2019
-
负责人:毛开睿
-
依托单位:
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
-
批准号:51678163
-
项目类别:面上项目
-
资助金额:64.0万元
-
批准年份:2016
-
负责人:许玫英
-
依托单位: